101 related articles for article (PubMed ID: 2696739)
21. Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice.
Sebti SM; Tkalcevic GT; Jani JP
Cancer Commun; 1991 May; 3(5):141-7. PubMed ID: 2043425
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
Panet R; Marcus M; Atlan H
J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
[TBL] [Abstract][Full Text] [Related]
23. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation.
Hamel E; Katoh F; Mueller G; Birchmeier W; Yamasaki H
Cancer Res; 1988 May; 48(10):2832-6. PubMed ID: 3258789
[TBL] [Abstract][Full Text] [Related]
25. In vivo and in vitro effects of v-fos and EJ-Ha-ras oncogene expression in murine epidermal keratinocytes.
Appleby MW; Greenfield IM; Crook T; Parkinson EK; Stanley MA
Oncogene; 1989 Nov; 4(11):1323-30. PubMed ID: 2682460
[TBL] [Abstract][Full Text] [Related]
26. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
[TBL] [Abstract][Full Text] [Related]
27. Lack of c-jun expression in a transformed cell line isolated by glucocorticoid promotion of ras-transfected rat embryo fibroblasts.
Marshall H; Popowicz P; Engel G; Martens I; Linder S
Oncogene; 1993 May; 8(5):1303-9. PubMed ID: 8479751
[TBL] [Abstract][Full Text] [Related]
28. EGF receptor activity and mitogenic response of Balb/3T3 cells expressing Ras and Myc oncogenes. EGF receptor activity in oncogene transformed cells.
Gopas J; Ono M; Princler G; Smith MR; Tainsky MA; Siddiqui MA; Wishniak O; Segal S; Kuwano M; Kung HF
Cell Mol Biol; 1992 Sep; 38(6):605-14. PubMed ID: 1303308
[TBL] [Abstract][Full Text] [Related]
29. Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway.
De Santis ML; Kannan S; Smith GH; Seno M; Bianco C; Kim N; Martinez-Lacaci I; Wallace-Jones B; Salomon DS
Cell Growth Differ; 1997 Dec; 8(12):1257-66. PubMed ID: 9419414
[TBL] [Abstract][Full Text] [Related]
30. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.
Dartsch PC; Ritter M; Häussinger D; Lang F
Eur J Cell Biol; 1994 Apr; 63(2):316-25. PubMed ID: 8082656
[TBL] [Abstract][Full Text] [Related]
31. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
[TBL] [Abstract][Full Text] [Related]
32. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
Xin H; Geng Y; Pramanik R; Choubey D
J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
[TBL] [Abstract][Full Text] [Related]
33. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
34. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
Storer RD; Allen HL; Kraynak AR; Bradley MO
Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
[TBL] [Abstract][Full Text] [Related]
35. Ras-inducible immortalized fibroblasts: focus formation without cell cycle deregulation.
Jacobsen K; Groth A; Willumsen BM
Oncogene; 2002 May; 21(19):3058-67. PubMed ID: 12082537
[TBL] [Abstract][Full Text] [Related]
36. Effect of glucocorticoids on oncogene transformed NIH3T3 cells.
Matin A; Cheng KL; Suen TC; Hung MC
Oncogene; 1990 Jan; 5(1):111-6. PubMed ID: 2181373
[TBL] [Abstract][Full Text] [Related]
37. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
Zhao J; Buick RN
Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
[TBL] [Abstract][Full Text] [Related]
38. Activation of p21ras is not sufficient to ensure a complete G1 phase of the cell division cycle in mouse fibroblasts.
Gaben AM; Saucier C; Bedin M; Barbu V; Courilleau D; Bon-Hoa DH; Mester J
Oncogene; 1996 Nov; 13(10):2113-20. PubMed ID: 8950978
[TBL] [Abstract][Full Text] [Related]
39. Ras- and Raf-mediated regulation of transforming growth factor beta 1 gene expression by ligands of tyrosine kinase receptors in PC12 cells.
Cosgaya JM; Aranda A
Oncogene; 1996 Jun; 12(12):2651-60. PubMed ID: 8700524
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
